97 related articles for article (PubMed ID: 7506303)
1. Detection of activated platelets in urinary sediments by immunofluorescence using monoclonal antibody to human platelet GMP-140 in patients with IgA nephropathy.
Tomino Y; Tsushima Y; Ohmuro H; Shimizu M; Kuramoto T; Shirato I; Koide H
J Clin Lab Anal; 1993; 7(6):329-33. PubMed ID: 7506303
[TBL] [Abstract][Full Text] [Related]
2. Detection of 'activated platelets' in the urinary sediments using a scanning electron microscope in patients with IgA nephropathy.
Shirato I; Tomino Y; Koide H
Am J Nephrol; 1990; 10(3):186-90. PubMed ID: 2200268
[TBL] [Abstract][Full Text] [Related]
3. Detection of activated platelets in urine by double immunofluorescence in children with IgA nephropathy.
Kamitsuji H; Nakajima M; Kawahara S; Nishimura T
Nephron; 1998; 78(2):162-7. PubMed ID: 9496732
[TBL] [Abstract][Full Text] [Related]
4. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
Taira K; Hewitson TD; Kincaid-Smith P
Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble Fas and disease activity in patients with IgA nephropathy.
Shou I; Tashiro K; Kurusu A; Kaneko S; Hayashi T; Fukui M; Shirato I; Kubota K; Tomino Y
Nephron; 1999; 81(4):387-92. PubMed ID: 10095173
[TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.
Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Sekizuka K; Ebihara I; Koide H
Am J Nephrol; 2000; 20(5):373-9. PubMed ID: 11092994
[TBL] [Abstract][Full Text] [Related]
7. Podocytopenia and disease severity in IgA nephropathy.
Lemley KV; Lafayette RA; Safai M; Derby G; Blouch K; Squarer A; Myers BD
Kidney Int; 2002 Apr; 61(4):1475-85. PubMed ID: 11918755
[TBL] [Abstract][Full Text] [Related]
8. Urinary levels of interleukin-6 and disease activity in patients with IgA nephropathy.
Tomino Y; Funabiki K; Ohmuro H; Shimizu M; Yokoyama K; Shirato I; Shirai T; Takahashi M; Koide H
Am J Nephrol; 1991; 11(6):459-64. PubMed ID: 1819212
[TBL] [Abstract][Full Text] [Related]
9. Preparation of a monoclonal antibody, SZ-51, that recognizes an alpha-granule membrane protein (GMP-140) on the surface of activated human platelets.
Wu G; Xi X; Li P; Chu X; Ruan C
Nouv Rev Fr Hematol (1978); 1990; 32(4):231-5. PubMed ID: 1705321
[TBL] [Abstract][Full Text] [Related]
10. Tubulointerstitial changes are less important in membranoproliferative glomerulonephritis than in IgA nephropathy.
Soma J; Ootaka T; Sato H; Ito S; Saito T
Nephron; 2000 Oct; 86(2):230-1. PubMed ID: 11015015
[No Abstract] [Full Text] [Related]
11. Siblings with IgA nephropathy and diffuse proliferative glomerulonephritis (PGN) associated with identical HL-A antigens.
Miura M; Tomino Y; Yagame M; Suga T; Endoh M; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1986 Nov; 11(5):323-7. PubMed ID: 3313816
[TBL] [Abstract][Full Text] [Related]
12. [Detection of circulating activated platelets by anti-GMP-140 monoclonal antibodies].
Tanoue K; Akamatsu N; Suzuki H; Katagiri Y; Yamazaki H; Fujimoto T; Fukuda S; Onozawa Y
Nihon Rinsho; 1992 Feb; 50(2):330-5. PubMed ID: 1377293
[TBL] [Abstract][Full Text] [Related]
13. [A study of urinary podocalyxin in children with IgA nephropathy].
Okubo S
Nihon Jinzo Gakkai Shi; 1995 Jul; 37(7):357-65. PubMed ID: 7637206
[TBL] [Abstract][Full Text] [Related]
14. Detection of activated platelets using activation-dependent monoclonal antibody (SZ-51) in clinical disorders.
Wu G; Li F; Li P; Li J; Ruan C
Nouv Rev Fr Hematol (1978); 1992; 34(1):31-5. PubMed ID: 1381818
[TBL] [Abstract][Full Text] [Related]
15. IgA nephropathy associated with polycythaemia vera: accelerated course.
Kasuno K; Ono T; Kamata T; Kawamura T; Suyama K; Oyama A; Matsushima H; Kuwahara T; Muso E; Sasayama S
Nephrol Dial Transplant; 1997 Jan; 12(1):212-5. PubMed ID: 9027804
[No Abstract] [Full Text] [Related]
16. Effect of serum from patients with mesangial proliferative glomerulonephritis on cultured rat mesangial cells.
Nukii K; Kakizaki Y; Waga S
Tohoku J Exp Med; 1994 Oct; 174(2):109-18. PubMed ID: 7900151
[TBL] [Abstract][Full Text] [Related]
17. Immunofluorescent studies on IgA nephropathy: type IV collagen and glomerular basement membrane component detected by Goodpasture's syndrome serum and laminin.
Tomino Y; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1988 Aug; 13(3):137-43. PubMed ID: 3075823
[TBL] [Abstract][Full Text] [Related]
18. Production of a monoclonal antibody against canine GMP-140 (P-selectin) and studies of its vascular distribution in canine tissues.
Doré M; Hawkins HK; Entman ML; Smith CW
Vet Pathol; 1993 May; 30(3):213-22. PubMed ID: 7687399
[TBL] [Abstract][Full Text] [Related]
19. Effect of immunoglobulin depositions of glomerular sialic acids in patients with IgA nephropathy.
Tomino Y; Sakai H; Miura M; Suga T; Yagame M; Endoh M; Nomoto Y
Am J Nephrol; 1986; 6(3):187-92. PubMed ID: 3526892
[TBL] [Abstract][Full Text] [Related]
20. Correlations among expression of glomerular intercellular adhesion molecule 1 (ICAM-1), levels of serum soluble ICAM-1, and renal histopathology in patients with IgA nephropathy.
Nguyen TT; Shou I; Funabiki K; Shirato I; Kubota K; Tomino Y
Am J Nephrol; 1999; 19(4):495-9. PubMed ID: 10460941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
